1 not yet recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Not yet recruiting 1 |
Follow imetelstat: new trials by email Literature Review of imetelstat trials Research Report on imetelstat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial Evaluating Two Imetelstat Doses in Participants With Lower Risk Myelodysplastic Syndrome (MDS) Imetelstat (7.1 mg/kg), Imetelstat (3.55 mg/kg) - MDS (Myelodysplastic Syndrome), MDS | Phase 4 | Not yet recruiting | Geron Corporation | 100 | 2027-03-01 | 2026-11-16 |
Anemia, Refractory, with Excess of Blasts (1)
Joseph E Eid, MD (1)